cabozantinib demonstrates disease control in advanced adrenocortical carcinoma
Published 2 years ago • 153 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
1:23
cabaten/getne-t1914: cabozantinib plus atezolizumab in adrenocortical carcinoma
-
0:39
current first-line therapies for patients with advanced adrenocortical carcinoma
-
0:36
managing adrenocortical carcinoma with immunotherapies
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
2:43
cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced rcc
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
1:26
neoadjuvant cabozantinib in patients with locally advanced non-metastatic ccrcc
-
3:54
papmet2: cabozantinib with or without atezolizumab in prcc
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
3:56
comparative efficacy of cabozantinib and regorafenib for advanced hepatocellular carcinoma
-
2:28
the role of cabozantinib in renal cell carcinoma
-
2:45
sequencing with cabozantinib in advanced hcc
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability
-
12:41
cabozantinib in combination with atezolizumab in patients with mcrpc
-
1:25
managing side effects of cabozantinib treatment for metastatic renal cell carcinoma
-
1:43
understanding variant histologies in urothelial carcinoma: io and cabozantinib's potential
-
1:05
effect of cabozantinib on quality of life in renal cell carcinoma